Influenza neuraminidase-inhibiting antibodies are induced in the presence of zanamivir (Q30399269)

21 June 2017

title

Influenza neuraminidase-inhibiting antibodies are induced in the presence of zanamivir (English)

1 reference

21 June 2017

1 reference

Maryna C Eichelberger

series ordinal

4

object named as

Maryna C Eichelberger

1 reference

21 June 2017

Ishrat Sultana

1

1 reference

21 June 2017

Jin Gao

series ordinal

2

1 reference

21 June 2017

Lewis Markoff

series ordinal

3

1 reference

21 June 2017

language of work or name

English

0 references

publication date

1 February 2011

1 reference

21 June 2017

1 reference

21 June 2017

volume

29

1 reference

21 June 2017

issue

14

1 reference

21 June 2017

page(s)

2601-2606

1 reference

Immunization against influenza A virus: comparison of conventional inactivated, live-attenuated and recombinant baculovirus produced purified hemagglutinin and neuraminidase vaccines in a murine model system

21 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.047

Supplementation of conventional influenza A vaccine with purified viral neuraminidase results in a balanced and broadened immune response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.047

Effect of neuraminidase antibody on Hong Kong influenza

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.047

The size and shape of influenza virus neuraminidase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.047

Structure of the catalytic and antigenic sites in influenza virus neuraminidase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.047

Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 A resolution

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.047

The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.047

Variation in the divalent cation requirements of influenza A virus N1 neuraminidases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.047

The annual production cycle for influenza vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.047

Effect of Ca++ on the stability of influenza virus neuraminidase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.047

Three-dimensional structure of a complex of antibody with influenza virus neuraminidase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.047

The neuraminidase of influenza virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.047

Three-dimensional structure of the complex of 4-guanidino-Neu5Ac2en and influenza virus neuraminidase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.047

A miniaturized assay for influenza neuraminidase-inhibiting antibodies utilizing reverse genetics-derived antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.047

Rapid selection of a transmissible multidrug-resistant influenza A/H3N2 virus in an immunocompromised host

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.047

Measurement of anti-influenza neuraminidase antibody using a peroxidase-linked lectin and microtitre plates coated with natural substrates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.047

Recombinant influenza B virus HA and NA antigens administered in equivalent amounts are immunogenically equivalent and induce equivalent homotypic and broader heterovariant protection in mice than conventional and live influenza vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.047

Association of serum anti-neuraminidase antibody with resistance to influenza in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.047

Induction of Partial Immunity to Influenza by a Neuraminidase-specific Vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.047

Antibody quantity versus quality after influenza vaccination

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.047

Purified influenza A virus N2 neuraminidase vaccine is immunogenic and non-toxic in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.047

Qualitative and quantitative analyses of virtually all subtypes of influenza A and B viral neuraminidases using antibodies targeting the universally conserved sequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.047

A high dosage influenza vaccine induced significantly more neuraminidase antibody than standard vaccine among elderly subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.047

Rational design of potent sialidase-based inhibitors of influenza virus replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.047

A practical influenza neutralization assay to simultaneously quantify hemagglutinin and neuraminidase-inhibiting antibody responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.047

Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.047

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2011.01.047

1 reference

21 June 2017

1 reference